Alpha adrenergic blockers – Tolazoline MCQs With Answer

Alpha adrenergic blockers – Tolazoline MCQs With Answer

This concise, B.Pharm-focused introduction reviews alpha adrenergic blockers with emphasis on tolazoline, an imidazoline-derived, short-acting nonselective alpha antagonist. Key points covered include mechanism of action (alpha-1 and alpha-2 blockade), pharmacokinetics, clinical uses such as neonatal pulmonary vasodilation, hemodynamic effects, adverse reactions, drug interactions and important distinctions from phentolamine, phenoxybenzamine and selective alpha-1 blockers. The following material is crafted to reinforce pharmacology concepts, receptor selectivity, dosing considerations, contraindications and exam-oriented facts. Practical clinical correlations and mechanistic questions will help you prepare for university exams and pharmacy practice. Now let’s test your knowledge with 50 MCQs on this topic.

Q1. Which best describes the receptor selectivity of tolazoline?

  • Highly selective alpha-1 antagonist
  • Selective beta-1 antagonist
  • Nonselective alpha adrenergic antagonist
  • Selective alpha-2 agonist

Correct Answer: Nonselective alpha adrenergic antagonist

Q2. The primary hemodynamic effect of tolazoline is:

  • Direct myocardial depression causing reduced heart rate
  • Vasodilation resulting in decreased peripheral resistance
  • Pulmonary vasoconstriction and increased afterload
  • Selective venoconstriction without arterial effects

Correct Answer: Vasodilation resulting in decreased peripheral resistance

Q3. Which clinical indication is tolazoline most historically associated with?

  • Treatment of chronic hypertension in adults
  • Management of neonatal persistent pulmonary hypertension
  • Long-term therapy for benign prostatic hyperplasia
  • Prophylaxis of migraine headaches

Correct Answer: Management of neonatal persistent pulmonary hypertension

Q4. Tolazoline belongs chemically to which class?

  • Benzodiazepines
  • Imidazoline derivatives
  • Sulfonylureas
  • Calcium channel blockers

Correct Answer: Imidazoline derivatives

Q5. Blocking presynaptic alpha-2 receptors by tolazoline leads to which immediate neurotransmitter effect?

  • Decreased acetylcholine release
  • Increased norepinephrine release
  • Blockade of serotonin reuptake
  • Inhibition of dopamine synthesis

Correct Answer: Increased norepinephrine release

Q6. Which adverse effect is commonly associated with tolazoline due to reflex responses?

  • Bradycardia without blood pressure change
  • Reflex tachycardia
  • Prolonged QT interval exclusively
  • Severe hypoglycemia

Correct Answer: Reflex tachycardia

Q7. Compared to phenoxybenzamine, tolazoline is best characterized as:

  • An irreversible alpha blocker with long duration
  • A reversible, short-acting alpha antagonist
  • A beta-blocker with partial agonist activity
  • An angiotensin receptor blocker

Correct Answer: A reversible, short-acting alpha antagonist

Q8. The phenomenon where epinephrine causes a fall in blood pressure after alpha blockade is called:

  • Beta potentiation
  • Epinephrine reversal
  • Alpha augmentation
  • Noradrenergic surge

Correct Answer: Epinephrine reversal

Q9. Which route of administration is most commonly used for tolazoline in acute care?

  • Oral tablet
  • Intravenous injection
  • Topical cream
  • Inhalational aerosol

Correct Answer: Intravenous injection

Q10. Which effect on cardiac output is expected after tolazoline administration in a normovolemic patient?

  • Decreased cardiac output due to reduced contractility
  • Unchanged cardiac output in all cases
  • Increased cardiac output secondary to decreased afterload
  • Immediate cardiac arrest risk in therapeutic doses

Correct Answer: Increased cardiac output secondary to decreased afterload

Q11. Which statement about tolazoline metabolism/excretion is most accurate?

  • Excreted unchanged primarily via the lungs
  • Extensively metabolized in the liver with renal excretion of metabolites
  • Eliminated solely by biliary excretion unchanged
  • Not metabolized and accumulates in adipose tissue

Correct Answer: Extensively metabolized in the liver with renal excretion of metabolites

Q12. Which contraindication is most relevant for tolazoline use?

  • Severe hypotension or hypovolemic shock
  • Controlled benign hypertension on monotherapy
  • Mild seasonal allergies
  • Asymptomatic hyperlipidemia

Correct Answer: Severe hypotension or hypovolemic shock

Q13. Which drug interaction is most likely with tolazoline?

  • Potentiation of hypotensive effect with other antihypertensives
  • Marked increase in digoxin clearance
  • Prevention of warfarin metabolism causing clotting
  • Complete antagonism of acetaminophen analgesia

Correct Answer: Potentiation of hypotensive effect with other antihypertensives

Q14. Which diagnostic or therapeutic use is tolazoline least likely to be used for?

  • Short-term pulmonary vasodilation in neonates
  • Phentolamine-like testing for pheochromocytoma
  • Long-term outpatient blood pressure control
  • Reversal of peripheral vasospasm in some settings

Correct Answer: Long-term outpatient blood pressure control

Q15. Which physiologic response occurs when alpha-2 receptors are blocked centrally or peripherally?

  • Decreased sympathetic outflow causing bradycardia
  • Enhanced presynaptic inhibition of norepinephrine
  • Increased sympathetic neurotransmitter release
  • Selective increase in acetylcholine release at neuromuscular junction

Correct Answer: Increased sympathetic neurotransmitter release

Q16. Compared with prazosin, tolazoline differs because tolazoline:

  • Is a selective alpha-1 antagonist
  • Has irreversible binding to alpha receptors
  • Is nonselective and blocks alpha-2 receptors as well
  • Is administered orally once daily

Correct Answer: Is nonselective and blocks alpha-2 receptors as well

Q17. Which adverse effect may be specifically worsened by alpha-2 blockade from tolazoline?

  • Hypoglycemia from insulin release
  • Exaggerated tachycardia due to increased norepinephrine
  • Profound bradycardia due to vagal stimulation
  • Severe constipation due to decreased GI motility

Correct Answer: Exaggerated tachycardia due to increased norepinephrine

Q18. Which statement about tolazoline’s onset and duration is correct?

  • Slow onset and very long duration (days)
  • Rapid onset with short duration of action
  • Requires metabolic activation to become active
  • Onset only after oral administration due to enterohepatic recycling

Correct Answer: Rapid onset with short duration of action

Q19. Which monitoring parameter is essential after tolazoline administration?

  • Serum potassium every 6 hours
  • Continuous blood pressure and heart rate monitoring
  • Daily thyroid function tests
  • Routine platelet counts

Correct Answer: Continuous blood pressure and heart rate monitoring

Q20. In an overdose causing severe hypotension, which immediate measure is appropriate?

  • Administer a high-dose alpha agonist such as norepinephrine with careful titration
  • Give an oral beta-agonist
  • Begin high-dose insulin therapy
  • Administer naloxone

Correct Answer: Administer a high-dose alpha agonist such as norepinephrine with careful titration

Q21. Which effect on pulmonary vasculature is associated with tolazoline?

  • Pulmonary vasoconstriction increasing pulmonary artery pressure
  • Pulmonary vasodilation reducing pulmonary vascular resistance
  • No effect on pulmonary vessels
  • Selective bronchoconstriction without vascular effects

Correct Answer: Pulmonary vasodilation reducing pulmonary vascular resistance

Q22. Which patient population requires special caution when using tolazoline?

  • Neonates with pulmonary hypertension
  • Patients with coronary artery disease
  • Young healthy athletes
  • Patients with mild seasonal rhinitis

Correct Answer: Patients with coronary artery disease

Q23. Which pharmacologic effect distinguishes reversible competitive alpha blockers like tolazoline from irreversible blockers?

  • Effect lasts until new receptors are synthesized
  • Receptor blockade can be overcome by increasing agonist concentration
  • Irreversible blockers have a shorter duration than reversible ones
  • Reversible blockers cause permanent receptor downregulation

Correct Answer: Receptor blockade can be overcome by increasing agonist concentration

Q24. Which laboratory or clinical sign might indicate excessive alpha blockade?

  • Marked hypertension with bradycardia
  • Profound orthostatic hypotension and tachycardia
  • Elevated serum creatinine kinase only
  • Hyperreflexia and muscle spasm

Correct Answer: Profound orthostatic hypotension and tachycardia

Q25. When given with a nonselective beta blocker, tolazoline might cause:

  • Enhanced reflex tachycardia
  • Unopposed beta-2 activity leading to bronchospasm
  • Marked hypotension without reflex tachycardia
  • Immediate hypertensive crisis

Correct Answer: Marked hypotension without reflex tachycardia

Q26. Which statement about tolazoline and histamine is correct?

  • Tolazoline has no effect on histamine release
  • Tolazoline may cause histamine release leading to flushing
  • Tolazoline is an antihistamine and prevents allergic reactions
  • Tolazoline selectively blocks H2 receptors

Correct Answer: Tolazoline may cause histamine release leading to flushing

Q27. Which adverse CNS effect has been reported with alpha-2 blockade by agents like tolazoline?

  • Excessive sedation and coma in all patients
  • CNS stimulation with agitation or seizures in susceptible individuals
  • Specific neuroprotection against ischemic stroke
  • Complete loss of smell (anosmia)

Correct Answer: CNS stimulation with agitation or seizures in susceptible individuals

Q28. Which statement about tolazoline dosing strategy in acute neonatal use is appropriate?

  • Single fixed oral dose is standard
  • Continuous IV infusion with careful titration to response is commonly used
  • Intramuscular administration is preferred for rapid effect
  • Aerosolized delivery is the standard of care

Correct Answer: Continuous IV infusion with careful titration to response is commonly used

Q29. Which effect on renal blood flow is expected after alpha blockade with tolazoline?

  • Decreased renal blood flow due to vasoconstriction
  • Increased renal blood flow secondary to vasodilation
  • No change because kidneys lack alpha receptors
  • Marked renal artery thrombosis risk

Correct Answer: Increased renal blood flow secondary to vasodilation

Q30. Which statement about tachyphylaxis or tolerance development to tolazoline is true?

  • Tolazoline is associated with rapid tachyphylaxis making repeated doses ineffective
  • Short-term use shows less tolerance than chronic therapy; long-term use not recommended
  • Tolerance leads to permanent receptor loss
  • Tolazoline efficacy increases with repeated dosing due to receptor upregulation

Correct Answer: Short-term use shows less tolerance than chronic therapy; long-term use not recommended

Q31. Which is a correct comparison between tolazoline and phentolamine?

  • Both are irreversible alpha antagonists
  • Tolazoline is more commonly used than phentolamine for pheochromocytoma testing
  • Both are reversible nonselective alpha antagonists with similar acute effects
  • Phentolamine is a selective alpha-1 agonist unlike tolazoline

Correct Answer: Both are reversible nonselective alpha antagonists with similar acute effects

Q32. Which vital sign change requires immediate attention after tolazoline?

  • Mild transient warmth of extremities
  • Systolic blood pressure drop of >30 mmHg with altered mentation
  • Small increase in appetite
  • Isolated mild ankle edema without hemodynamic changes

Correct Answer: Systolic blood pressure drop of >30 mmHg with altered mentation

Q33. Which laboratory parameter may need monitoring during prolonged alpha-blocker therapy?

  • Serum magnesium exclusively
  • Renal function and electrolyte status
  • Bone marrow biopsy weekly
  • Fasting insulin only

Correct Answer: Renal function and electrolyte status

Q34. Which of the following best explains why alpha-2 blockade can increase sympathetic activity?

  • Alpha-2 blockade directly stimulates acetylcholine release
  • Alpha-2 receptors normally inhibit norepinephrine release; blocking them increases release
  • Blocking alpha-2 reduces catecholamine synthesis
  • Alpha-2 blockade causes permanent depletion of norepinephrine stores

Correct Answer: Alpha-2 receptors normally inhibit norepinephrine release; blocking them increases release

Q35. Which cardiovascular contraindication should be considered before giving tolazoline?

  • Uncontrolled angina or recent myocardial infarction
  • Mild controlled bradycardia without symptoms
  • Stable peripheral neuropathy
  • Hyperthyroidism under treatment

Correct Answer: Uncontrolled angina or recent myocardial infarction

Q36. Which effect on systemic vascular resistance (SVR) follows tolazoline?

  • SVR increases markedly
  • SVR decreases due to arterial and arteriolar dilation
  • No change in SVR; only heart rate changes
  • SVR oscillates unpredictably without pattern

Correct Answer: SVR decreases due to arterial and arteriolar dilation

Q37. Which clinical scenario could worsen with tolazoline because of increased sympathetic activity from alpha-2 blockade?

  • Patients with tachyarrhythmias or unstable ischemic heart disease
  • Patients with stable hypothyroidism
  • Individuals with well-controlled eczema
  • Patients on stable statin therapy

Correct Answer: Patients with tachyarrhythmias or unstable ischemic heart disease

Q38. Which statement about tolazoline’s effect on peripheral resistance and venous return is correct?

  • It causes venoconstriction and increases venous return
  • It causes both arteriolar and venous dilation, potentially reducing venous return
  • It exclusively affects lymphatic vessels with no hemodynamic change
  • It selectively increases preload without affecting afterload

Correct Answer: It causes both arteriolar and venous dilation, potentially reducing venous return

Q39. Which monitoring is particularly important in neonates treated with tolazoline for pulmonary hypertension?

  • Serial hemoglobin A1c levels
  • Continuous pulse oximetry and arterial blood gases
  • Weekly liver ultrasound
  • Fasting lipid profile every 12 hours

Correct Answer: Continuous pulse oximetry and arterial blood gases

Q40. Which is a correct statement about tolerance or rebound phenomena after stopping tolazoline?

  • Sudden withdrawal may cause rebound hypertension in some settings
  • There is no physiologic rebound after discontinuation
  • Discontinuation causes permanent alpha receptor upregulation
  • Stopping tolazoline results in irreversible loss of effect

Correct Answer: Sudden withdrawal may cause rebound hypertension in some settings

Q41. Which laboratory or diagnostic test could help differentiate alpha blockade effects clinically?

  • Measurement of pupillary reflexes only
  • Pressor response test with phenylephrine or epinephrine under monitored conditions
  • Routine chest X-ray exclusively
  • Electroencephalogram as first-line test

Correct Answer: Pressor response test with phenylephrine or epinephrine under monitored conditions

Q42. Which side effect is less likely with tolazoline compared to irreversible alpha antagonists?

  • Short-lived hypotension that resolves with drug clearance
  • Permanent nasal congestion for months
  • Long-term tachycardia lasting weeks after single dose
  • Persistent receptor blockade requiring new receptor synthesis

Correct Answer: Short-lived hypotension that resolves with drug clearance

Q43. Which best describes the pharmacodynamic interaction between tolazoline and indirect sympathomimetics?

  • Alpha blockade enhances the vasopressor effect of indirect sympathomimetics
  • Alpha blockade attenuates alpha-mediated vasoconstriction, potentially unmasking beta-mediated vasodilation
  • Alpha blockers convert indirect sympathomimetics into direct cholinergic agonists
  • There is no interaction; they act on unrelated pathways

Correct Answer: Alpha blockade attenuates alpha-mediated vasoconstriction, potentially unmasking beta-mediated vasodilation

Q44. Which pharmacological property makes tolazoline suitable for short-term intravenous use in acute settings?

  • High oral bioavailability for outpatient therapy
  • Rapid onset and short duration allowing tight titration
  • Requirement for hepatic activation before effect
  • Extremely long half-life permitting once weekly dosing

Correct Answer: Rapid onset and short duration allowing tight titration

Q45. Which cardiovascular index typically rises transiently after nonselective alpha blockade due to reflex mechanisms?

  • Systemic vascular resistance (SVR)
  • Heart rate
  • Left ventricular afterload permanently
  • Absolute oxygen extraction by tissues

Correct Answer: Heart rate

Q46. Which patient symptom during tolazoline infusion should prompt immediate dose reduction or cessation?

  • Warm sensation in extremities without hemodynamic change
  • Severe dizziness with systolic pressure drop and decreased perfusion
  • Transient mild headache resolving spontaneously
  • Minor injection site tenderness

Correct Answer: Severe dizziness with systolic pressure drop and decreased perfusion

Q47. Which statement about combining tolazoline with beta-blockers is true?

  • Combination is always safe and increases blood pressure
  • Beta-blockers may prevent reflex tachycardia but increase risk of hypotension and unopposed alpha effects
  • Beta-blockers neutralize histamine release associated with tolazoline
  • There are no clinically relevant interactions

Correct Answer: Beta-blockers may prevent reflex tachycardia but increase risk of hypotension and unopposed alpha effects

Q48. Which adverse gastrointestinal effect can occur with alpha blockade?

  • Marked constipation due to increased motility
  • Nausea and vomiting due to hypotension and sympathetic changes
  • Immediate ulceration of gastric mucosa in all patients
  • Complete inhibition of pancreatic enzyme secretion

Correct Answer: Nausea and vomiting due to hypotension and sympathetic changes

Q49. Which pharmacologic attribute is important when selecting tolazoline over longer-acting alpha blockers in acute care?

  • Long duration to avoid frequent dosing
  • Short duration to allow rapid reversal of effect if needed
  • High oral bioavailability for continuous outpatient infusion
  • Selective beta activity to spare alpha receptors

Correct Answer: Short duration to allow rapid reversal of effect if needed

Q50. Which teaching point is most important for B.Pharm students learning about tolazoline?

  • It is a first-line oral antihypertensive for chronic therapy
  • Understand receptor selectivity, acute hemodynamic effects, adverse reactions and careful monitoring when used IV
  • It has no cardiovascular effects and is safe without monitoring
  • It is only used as an over-the-counter topical agent

Correct Answer: Understand receptor selectivity, acute hemodynamic effects, adverse reactions and careful monitoring when used IV

Author

  • G S Sachin
    : Author

    G S Sachin is a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. He holds a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research and creates clear, accurate educational content on pharmacology, drug mechanisms of action, pharmacist learning, and GPAT exam preparation.

    Mail- Sachin@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators